TY - JOUR
T1 - Antiphospholipid antibody syndrome and adrenal insufficiency in a 15- year-old girl
AU - Prahalad, Sampath
AU - Ostrov, Barbara E.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 1998/4
Y1 - 1998/4
N2 - Antiphospholipid syndrome is increasingly recognized in children. This syndrome is manifested by arterial or venous thromboses, recurrent fetal loss, the presence of elevated titers of anticardiolipin antibodies, and/or the presence of a lupus anticoagulant. Adrenal insufficiency as a complication of this syndrome is rare. We describe adrenal insufficiency in a 15-year-old girl with a lupus anticoagulant and review this complication of the antiphospholipid syndrome in pediatric patients. Adrenal insufficiency is typically manifested by abdominal pain, hypotension, fever, and vomiting. Evaluation reveals hyponatremia, hyperkalemia, and metabolic acidosis. When suspected, adrenal insufficiency should be confirmed by a corticotrophin stimulation test. Prompt management of fluid and electrolyte disturbance along with the replacement of glucocorticoids and mineralcorticoids is necessary to treat this potentially fatal disorder in pediatric patients.
AB - Antiphospholipid syndrome is increasingly recognized in children. This syndrome is manifested by arterial or venous thromboses, recurrent fetal loss, the presence of elevated titers of anticardiolipin antibodies, and/or the presence of a lupus anticoagulant. Adrenal insufficiency as a complication of this syndrome is rare. We describe adrenal insufficiency in a 15-year-old girl with a lupus anticoagulant and review this complication of the antiphospholipid syndrome in pediatric patients. Adrenal insufficiency is typically manifested by abdominal pain, hypotension, fever, and vomiting. Evaluation reveals hyponatremia, hyperkalemia, and metabolic acidosis. When suspected, adrenal insufficiency should be confirmed by a corticotrophin stimulation test. Prompt management of fluid and electrolyte disturbance along with the replacement of glucocorticoids and mineralcorticoids is necessary to treat this potentially fatal disorder in pediatric patients.
UR - http://www.scopus.com/inward/record.url?scp=0031837465&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031837465&partnerID=8YFLogxK
U2 - 10.1097/00124743-199804000-00010
DO - 10.1097/00124743-199804000-00010
M3 - Article
C2 - 19078257
AN - SCOPUS:0031837465
SN - 1076-1608
VL - 4
SP - 87
EP - 91
JO - Journal of Clinical Rheumatology
JF - Journal of Clinical Rheumatology
IS - 2
ER -